Figure 1 Patients outside of target international normalized ratio range by time point and management strategy. All values are expressed as percentages.

Slides:



Advertisements
Similar presentations
From: An open day in the metric space
Advertisements

Figure 1 The spatial and temporal distribution of diarrhoea rates
Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted.
Fig. 1 Graphical representation
Figure 1: A PRISMA schematic of search strategy
Figure 2. CONSORT flow diagram.
Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.
Figure 1: Different aortic bioprostheses
Figure 1 Timeline of the project.
Fig. 1. TGF results in different group
Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.
Fig. 1. Patient transferred to ICU with IABP inserted surgically through left axillary artery approached at deltoido-pectoralis groove (a). Correct position.
Figure 1: Forest plots. M-H: Mantel-Haenszel test; CI: confidence interval; SD: standard deviation; IV: inverse variance. Suction on chest drains following.
Figure 1 Representative longitudinal strain analysis in an apical two-chamber view. The view is presented in the left panel and the longitudinal strain.
pSS: primary SS; Scl: scleroderma.
Figure 2: The Medical Imaging Projection System projecting the real-time fluorescent image on the surface of the lung during surgery (left). The cut surface.
Figure 1 Study flow chart.
Figure 1. Selection of papers.
Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Figure 4 Comparison of school and leisure time activity energy expenditure on weekdays between preschool and adolescent boys in different age categories.
Figure 1 Representative transoesophageal echocardiographic images of ventricular fibrillation during cardiopulmonary bypass. (A) Mid-oesophageal aortic.
Source: Authors’ elaboration with data from Eurostat.
Figure 1: Correlation of plasma ET-1 levels with LAD in patients with mitral valve disease. r is Pearson’s correlation coefficient. ET-1: endothelin 1;
From: Where do we go from here
Figure 1. Nonadherence to guidelines for prescribing antiplatelet and anticoagulant therapy in 144 patients with atrial fibrillation who attend a Spanish.
Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.
Figure 1 Study flowchart.
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Figure 1. Time of initiation of therapeutic hypothermia according to who initiated it. Note the logarithmic scaling of the vertical axis. From: Initiation.
Figure 1: Time points at which sperm samples were analysed for aneuploidy frequencies in controls and cancer patients From: Sperm aneuploidy frequencies.
Figure 1: Logistic regression showing association of prescribing provider and patient panel characteristics with occurrence of a hospitalization or ED.
Figure 1 Degrees of major and minor pulmonary fissure completeness.
Figure 1: IPW-adjusted cumulative incidence function of cardiac death at 12 years, with non-cardiac death as competing risk. IPW: inverse probability of.
Figure 2 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET. Odds ratio (OR) adjusted for clinical pregnancy (OR 0.90, 95% CI 0.73–1.12)
Figure 1 A model of national image
Figure 2 The final moderated mediation model: a differential indirect effect of personal issue importance on elaborative reasoning through pro- and counterattitudinal.
Table 2: Baseline characteristicsa of non-survivors and survivors and univariate logistic models predicting 30-day mortality From: The association.
Figure 3: Mean gradient according to valve size, 6 weeks after surgery
Figure 1. Progression-free survival and overall survival for FL/DLBCL patients. From: Clinicobiological features and prognostic impact of diffuse large.
Figure 1. Percentage of participants in each group (holocaust survivors, prewar immigrants, and postwar immigrants) by the main coded strategies. From:
Table 1 The 5 stages of constructing a BET
Abstract From: Lung transplantation after ex vivo lung perfusion in two Scandinavian centres Eur J Cardiothorac Surg. Published online October 29, 2018.
Hospital volume, mitral repair rates, and mortality in mitral valve surgery in the elderly: An analysis of US hospitals treating Medicare fee-for-service.
Figure 4. Influence of Clerk Ideology on Justice Voting.
Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.
Resuscitation practices in cardiac surgery
Figure 1 Study flow diagram and definition of clinical response
Figure 1 Data-selection process
A technique for implanting outflow cannulas for Berlin Heart EXCOR ventricular assist device in small pediatric patients  Khanh Nguyen, MD  The Journal.
Figure 1 ELECTRa registry patient flow diagram presenting the proportion of patients of the total enrolled patient ... Figure 1 ELECTRa registry patient.
Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology  Juan A. Crestanello, MD  The Journal of.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
Take home figure The 38% of heart failure reduced ejection fraction (HFrEF) patients who recovered LVEF (HFrecEF) were more ... Take home figure The 38%
Figure 1 Selection algorithm of patients being included in the German Aortic Valve Registry in 2014 and Figure 1 Selection algorithm of patients.
Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.
Figure 1 Immunohistochemistry for human cell differentiation molecules in samples of the right ventricular septum from ... Figure 1 Immunohistochemistry.
Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Patient selection
Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study  Nicholas C. Dang,
Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients  Pushpinder Sidhu, Hugh O O’Kane  The Annals.
Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices  Forum Kamdar, MD, Ranjit John,
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Patient selection.
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Optimal timing of cardiac transplantation after ventricular assist device implantation  James S Gammie, MD, Leah B Edwards, PhD, Bartley P Griffith, MD,
Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.
Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets  Juan A. Crestanello, MD  The Journal of Thoracic.
Figure 1 ABCDE of primary prevention.2
Presentation transcript:

Figure 1 Patients outside of target international normalized ratio range by time point and management strategy. All values are expressed as percentages. OSH-CC: outside hospital anticoagulation clinic; OSH-PCP: outside hospital system primary care provider; OSU-CC: implanting centre anticoagulation clinic; OSU-VAD: implanting centre ventricular assist device office. From: Anticoagulation management following left ventricular assist device implantation is similar across all provider strategies† Interact CardioVasc Thorac Surg. Published online August 14, 2017. doi:10.1093/icvts/ivx255 Interact CardioVasc Thorac Surg | © The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.